| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Firearms | 115 | 2024 | 631 | 21.710 |
Why?
|
| Homicide | 45 | 2022 | 294 | 10.230 |
Why?
|
| Wounds, Gunshot | 46 | 2024 | 586 | 7.480 |
Why?
|
| Violence | 46 | 2022 | 936 | 6.290 |
Why?
|
| Ownership | 28 | 2024 | 338 | 6.040 |
Why?
|
| Suicide | 44 | 2024 | 1606 | 5.440 |
Why?
|
| Police | 6 | 2024 | 158 | 2.960 |
Why?
|
| Public Health | 18 | 2024 | 2679 | 2.410 |
Why?
|
| Public Policy | 12 | 2021 | 552 | 2.110 |
Why?
|
| Accidents, Traffic | 15 | 2022 | 818 | 1.870 |
Why?
|
| Crime Victims | 14 | 2020 | 347 | 1.830 |
Why?
|
| Accident Prevention | 7 | 2019 | 76 | 1.750 |
Why?
|
| Accidents | 8 | 2017 | 164 | 1.740 |
Why?
|
| Wounds and Injuries | 15 | 2020 | 2517 | 1.710 |
Why?
|
| Crime | 11 | 2020 | 206 | 1.670 |
Why?
|
| Silicosis | 15 | 2001 | 47 | 1.260 |
Why?
|
| Carbonated Beverages | 4 | 2016 | 210 | 1.260 |
Why?
|
| Adolescent Behavior | 12 | 2021 | 1186 | 1.210 |
Why?
|
| Safety | 8 | 2019 | 1159 | 1.190 |
Why?
|
| Licensure | 3 | 2018 | 127 | 1.150 |
Why?
|
| United States | 112 | 2024 | 73039 | 1.130 |
Why?
|
| Population Surveillance | 15 | 2019 | 2596 | 1.110 |
Why?
|
| Cause of Death | 9 | 2022 | 3721 | 1.090 |
Why?
|
| Supreme Court Decisions | 3 | 2024 | 135 | 1.070 |
Why?
|
| Commerce | 5 | 2018 | 612 | 0.960 |
Why?
|
| Schools, Public Health | 2 | 2018 | 23 | 0.890 |
Why?
|
| Mortality | 8 | 2020 | 2911 | 0.850 |
Why?
|
| Data Collection | 20 | 2020 | 3327 | 0.800 |
Why?
|
| Family Characteristics | 6 | 2022 | 1003 | 0.790 |
Why?
|
| Law Enforcement | 3 | 2015 | 112 | 0.740 |
Why?
|
| Urban Population | 9 | 2020 | 2046 | 0.740 |
Why?
|
| Developed Countries | 3 | 2019 | 451 | 0.730 |
Why?
|
| Criminals | 1 | 2020 | 60 | 0.680 |
Why?
|
| Child Mortality | 1 | 2022 | 204 | 0.680 |
Why?
|
| Silicon Dioxide | 15 | 2001 | 218 | 0.670 |
Why?
|
| Urban Health | 2 | 2019 | 535 | 0.660 |
Why?
|
| Humans | 214 | 2024 | 768166 | 0.660 |
Why?
|
| Public Opinion | 4 | 2010 | 486 | 0.640 |
Why?
|
| Adolescent | 81 | 2022 | 89169 | 0.630 |
Why?
|
| Attitude | 5 | 2016 | 771 | 0.630 |
Why?
|
| Facility Design and Construction | 1 | 2019 | 86 | 0.630 |
Why?
|
| Resource Allocation | 1 | 2021 | 354 | 0.630 |
Why?
|
| Information Systems | 1 | 2020 | 400 | 0.620 |
Why?
|
| Domestic Violence | 6 | 2021 | 180 | 0.600 |
Why?
|
| Social Medicine | 1 | 2018 | 64 | 0.590 |
Why?
|
| Spouse Abuse | 6 | 2013 | 182 | 0.580 |
Why?
|
| Sex Distribution | 10 | 2019 | 2278 | 0.570 |
Why?
|
| Mass Casualty Incidents | 1 | 2019 | 180 | 0.560 |
Why?
|
| Government Programs | 2 | 2017 | 278 | 0.540 |
Why?
|
| Government Regulation | 1 | 2021 | 525 | 0.540 |
Why?
|
| Bicycling | 1 | 2017 | 177 | 0.510 |
Why?
|
| Male | 153 | 2024 | 364719 | 0.510 |
Why?
|
| Cross-Sectional Studies | 36 | 2024 | 26379 | 0.490 |
Why?
|
| Macrophages, Alveolar | 12 | 2000 | 415 | 0.490 |
Why?
|
| Risk-Taking | 6 | 2015 | 1023 | 0.480 |
Why?
|
| Child | 45 | 2024 | 80917 | 0.470 |
Why?
|
| Residence Characteristics | 6 | 2018 | 2118 | 0.470 |
Why?
|
| Automobile Driving | 8 | 2008 | 442 | 0.470 |
Why?
|
| Age Distribution | 12 | 2019 | 2873 | 0.470 |
Why?
|
| Housing | 3 | 2017 | 683 | 0.470 |
Why?
|
| Adult | 102 | 2022 | 223646 | 0.470 |
Why?
|
| Research | 3 | 2019 | 1979 | 0.450 |
Why?
|
| Prisoners | 5 | 2006 | 316 | 0.440 |
Why?
|
| Safety Management | 4 | 2019 | 765 | 0.440 |
Why?
|
| Alcohol Drinking | 16 | 2020 | 4045 | 0.430 |
Why?
|
| Female | 126 | 2024 | 397192 | 0.430 |
Why?
|
| Poisoning | 3 | 2013 | 252 | 0.420 |
Why?
|
| Rural Population | 3 | 2020 | 2325 | 0.410 |
Why?
|
| Patient Advocacy | 1 | 2015 | 362 | 0.400 |
Why?
|
| Aggression | 3 | 2014 | 750 | 0.400 |
Why?
|
| Consumer Product Safety | 3 | 2001 | 122 | 0.390 |
Why?
|
| Community Networks | 2 | 2011 | 202 | 0.380 |
Why?
|
| Bronchoalveolar Lavage Fluid | 25 | 2005 | 760 | 0.380 |
Why?
|
| Students | 7 | 2021 | 1744 | 0.380 |
Why?
|
| Lung | 32 | 2008 | 10099 | 0.370 |
Why?
|
| Automobiles | 2 | 2010 | 103 | 0.360 |
Why?
|
| Health Education | 1 | 2017 | 1059 | 0.360 |
Why?
|
| Asbestos, Crocidolite | 11 | 2008 | 18 | 0.360 |
Why?
|
| Infanticide | 1 | 2009 | 5 | 0.340 |
Why?
|
| Juvenile Delinquency | 4 | 2019 | 116 | 0.330 |
Why?
|
| Young Adult | 33 | 2022 | 60066 | 0.330 |
Why?
|
| Child, Preschool | 26 | 2024 | 42669 | 0.320 |
Why?
|
| Regression Analysis | 13 | 2015 | 6340 | 0.320 |
Why?
|
| Rage | 2 | 2006 | 29 | 0.320 |
Why?
|
| Suicide, Attempted | 4 | 2013 | 1409 | 0.310 |
Why?
|
| Boston | 18 | 2017 | 9374 | 0.310 |
Why?
|
| Child Behavior Disorders | 1 | 2013 | 812 | 0.310 |
Why?
|
| Middle Aged | 69 | 2020 | 223492 | 0.300 |
Why?
|
| Intention | 1 | 2011 | 347 | 0.300 |
Why?
|
| Social Environment | 3 | 2017 | 1012 | 0.290 |
Why?
|
| Lymphocytes | 7 | 2001 | 2614 | 0.290 |
Why?
|
| Cities | 3 | 2020 | 543 | 0.290 |
Why?
|
| Federal Government | 2 | 2020 | 266 | 0.290 |
Why?
|
| Self-Injurious Behavior | 3 | 2011 | 568 | 0.290 |
Why?
|
| Lead | 2 | 2024 | 882 | 0.280 |
Why?
|
| Policy Making | 2 | 2010 | 546 | 0.280 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 4055 | 0.280 |
Why?
|
| Health Surveys | 11 | 2017 | 4057 | 0.270 |
Why?
|
| Sex Factors | 13 | 2019 | 10632 | 0.270 |
Why?
|
| Atmosphere Exposure Chambers | 4 | 2000 | 51 | 0.270 |
Why?
|
| Massachusetts | 10 | 2022 | 8890 | 0.270 |
Why?
|
| Mice, Inbred C3H | 6 | 2000 | 915 | 0.270 |
Why?
|
| Health Status Disparities | 1 | 2018 | 1885 | 0.270 |
Why?
|
| State Government | 2 | 2020 | 388 | 0.270 |
Why?
|
| Risk Factors | 46 | 2019 | 74944 | 0.260 |
Why?
|
| Wounds, Stab | 1 | 2006 | 72 | 0.260 |
Why?
|
| Random Allocation | 7 | 2017 | 2396 | 0.260 |
Why?
|
| Criminal Law | 1 | 2006 | 97 | 0.250 |
Why?
|
| Bullying | 2 | 2019 | 234 | 0.250 |
Why?
|
| Multivariate Analysis | 17 | 2018 | 12077 | 0.250 |
Why?
|
| Poverty | 2 | 2017 | 2720 | 0.250 |
Why?
|
| Motor Vehicles | 3 | 2022 | 280 | 0.250 |
Why?
|
| Hostility | 1 | 2006 | 185 | 0.240 |
Why?
|
| Child Welfare | 2 | 2006 | 523 | 0.240 |
Why?
|
| Infant | 18 | 2024 | 36535 | 0.240 |
Why?
|
| Forensic Psychiatry | 1 | 2006 | 198 | 0.240 |
Why?
|
| Accidents, Home | 3 | 2005 | 73 | 0.240 |
Why?
|
| Agonistic Behavior | 1 | 2004 | 14 | 0.230 |
Why?
|
| Depressive Disorder | 2 | 2010 | 3721 | 0.230 |
Why?
|
| Carbon | 4 | 2000 | 673 | 0.220 |
Why?
|
| Prisons | 1 | 2006 | 178 | 0.220 |
Why?
|
| Prevalence | 18 | 2024 | 15869 | 0.220 |
Why?
|
| Rats, Inbred F344 | 29 | 2003 | 826 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 7 | 2000 | 506 | 0.220 |
Why?
|
| Incidence | 18 | 2010 | 21538 | 0.220 |
Why?
|
| Asbestos | 7 | 2005 | 251 | 0.210 |
Why?
|
| Depression | 4 | 2017 | 8230 | 0.210 |
Why?
|
| Urbanization | 2 | 2019 | 100 | 0.210 |
Why?
|
| Schools | 5 | 2016 | 1498 | 0.210 |
Why?
|
| Civil Rights | 1 | 2004 | 131 | 0.210 |
Why?
|
| Inhalation Exposure | 5 | 2005 | 432 | 0.210 |
Why?
|
| Interferon-gamma | 3 | 2001 | 3160 | 0.210 |
Why?
|
| History, 20th Century | 2 | 2021 | 2766 | 0.210 |
Why?
|
| Socioeconomic Factors | 11 | 2020 | 7852 | 0.210 |
Why?
|
| Registries | 5 | 2019 | 8375 | 0.210 |
Why?
|
| Social Control Policies | 1 | 2002 | 9 | 0.200 |
Why?
|
| Pediatrics | 2 | 2015 | 3629 | 0.200 |
Why?
|
| Spouses | 1 | 2005 | 286 | 0.200 |
Why?
|
| Fear | 3 | 2017 | 1495 | 0.200 |
Why?
|
| Air Movements | 2 | 2000 | 40 | 0.190 |
Why?
|
| California | 5 | 2010 | 1438 | 0.190 |
Why?
|
| Behavioral Risk Factor Surveillance System | 3 | 2015 | 211 | 0.190 |
Why?
|
| Utah | 2 | 2019 | 130 | 0.190 |
Why?
|
| Aged | 39 | 2019 | 171504 | 0.190 |
Why?
|
| Lobbying | 2 | 2010 | 32 | 0.190 |
Why?
|
| Security Measures | 1 | 2002 | 83 | 0.190 |
Why?
|
| Dust | 5 | 1998 | 488 | 0.190 |
Why?
|
| Sexual Partners | 4 | 2018 | 805 | 0.180 |
Why?
|
| Photometry | 1 | 2000 | 57 | 0.180 |
Why?
|
| Hip Fractures | 3 | 1995 | 997 | 0.180 |
Why?
|
| Health Facilities, Proprietary | 3 | 1991 | 37 | 0.180 |
Why?
|
| Capital Punishment | 1 | 2000 | 30 | 0.170 |
Why?
|
| Relief Work | 2 | 2011 | 131 | 0.170 |
Why?
|
| Social Control, Formal | 3 | 2001 | 107 | 0.170 |
Why?
|
| Body Height | 3 | 1995 | 1565 | 0.170 |
Why?
|
| Dangerous Behavior | 3 | 2005 | 65 | 0.170 |
Why?
|
| Australia | 2 | 2021 | 1265 | 0.170 |
Why?
|
| Income | 5 | 2004 | 1878 | 0.170 |
Why?
|
| Industrial Waste | 1 | 2019 | 24 | 0.170 |
Why?
|
| Nitrogen Dioxide | 5 | 2007 | 534 | 0.170 |
Why?
|
| Asbestos, Serpentine | 5 | 2003 | 24 | 0.170 |
Why?
|
| Lymphocyte Subsets | 2 | 2000 | 313 | 0.170 |
Why?
|
| Age Factors | 13 | 2011 | 18412 | 0.170 |
Why?
|
| Motorcycles | 1 | 1999 | 42 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 2709 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2010 | 2748 | 0.160 |
Why?
|
| Malpractice | 1 | 2004 | 561 | 0.160 |
Why?
|
| Research Support as Topic | 2 | 2016 | 696 | 0.160 |
Why?
|
| Infant, Newborn | 10 | 2019 | 26422 | 0.160 |
Why?
|
| Emigrants and Immigrants | 3 | 2011 | 550 | 0.160 |
Why?
|
| Databases as Topic | 1 | 2020 | 472 | 0.160 |
Why?
|
| Organizational Case Studies | 1 | 2019 | 301 | 0.160 |
Why?
|
| Physician's Role | 2 | 2016 | 925 | 0.160 |
Why?
|
| Michigan | 1 | 2019 | 330 | 0.160 |
Why?
|
| Education, Public Health Professional | 1 | 2018 | 27 | 0.150 |
Why?
|
| Head Protective Devices | 1 | 1999 | 118 | 0.150 |
Why?
|
| Peer Group | 3 | 2014 | 700 | 0.150 |
Why?
|
| Substance-Related Disorders | 4 | 2021 | 4423 | 0.150 |
Why?
|
| Women's Health | 2 | 2013 | 2082 | 0.150 |
Why?
|
| Silicic Acid | 1 | 1998 | 9 | 0.150 |
Why?
|
| Air Pollutants, Occupational | 1 | 2001 | 406 | 0.150 |
Why?
|
| Mental Health Services | 2 | 2008 | 1732 | 0.150 |
Why?
|
| Suicidal Ideation | 3 | 2013 | 1462 | 0.150 |
Why?
|
| Morals | 2 | 2012 | 288 | 0.150 |
Why?
|
| Equipment Safety | 1 | 2019 | 250 | 0.150 |
Why?
|
| Automation | 1 | 2000 | 589 | 0.150 |
Why?
|
| Lymphokines | 1 | 2001 | 924 | 0.150 |
Why?
|
| Health Expenditures | 1 | 2010 | 2389 | 0.140 |
Why?
|
| Social Behavior | 1 | 2004 | 1147 | 0.140 |
Why?
|
| Logistic Models | 11 | 2016 | 13290 | 0.140 |
Why?
|
| Smoking | 10 | 2004 | 9092 | 0.140 |
Why?
|
| Pleura | 5 | 2000 | 248 | 0.140 |
Why?
|
| Ambulatory Care Facilities | 4 | 1991 | 939 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2011 | 4640 | 0.140 |
Why?
|
| Health Behavior | 4 | 2015 | 2650 | 0.140 |
Why?
|
| Phagocytosis | 5 | 2000 | 1530 | 0.130 |
Why?
|
| Refugees | 3 | 2014 | 615 | 0.130 |
Why?
|
| Administration, Inhalation | 14 | 2008 | 1169 | 0.130 |
Why?
|
| Environmental Exposure | 4 | 2024 | 4543 | 0.130 |
Why?
|
| Vital Statistics | 1 | 2016 | 31 | 0.130 |
Why?
|
| Quartz | 3 | 1992 | 23 | 0.130 |
Why?
|
| Child Abuse | 3 | 2009 | 1091 | 0.130 |
Why?
|
| Interviews as Topic | 5 | 2006 | 2741 | 0.130 |
Why?
|
| Cytokines | 6 | 2008 | 7453 | 0.130 |
Why?
|
| Medical Errors | 1 | 2004 | 1260 | 0.130 |
Why?
|
| Censuses | 1 | 2017 | 198 | 0.130 |
Why?
|
| Aerosols | 10 | 2007 | 634 | 0.130 |
Why?
|
| Nitrates | 4 | 2003 | 260 | 0.130 |
Why?
|
| Asbestosis | 4 | 2008 | 81 | 0.130 |
Why?
|
| Mexico | 1 | 2017 | 769 | 0.120 |
Why?
|
| Acrolein | 2 | 2008 | 17 | 0.120 |
Why?
|
| Craniocerebral Trauma | 1 | 1999 | 493 | 0.120 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1765 | 0.120 |
Why?
|
| Escape Reaction | 1 | 1994 | 57 | 0.120 |
Why?
|
| Fractures, Bone | 3 | 1994 | 2062 | 0.120 |
Why?
|
| Occupational Diseases | 3 | 2011 | 1457 | 0.120 |
Why?
|
| Child Rearing | 1 | 1994 | 74 | 0.120 |
Why?
|
| Risk | 5 | 2017 | 9613 | 0.120 |
Why?
|
| Accidental Falls | 2 | 1994 | 1080 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 1998 | 1252 | 0.110 |
Why?
|
| Punishment | 1 | 1994 | 95 | 0.110 |
Why?
|
| Human Rights Abuses | 1 | 2014 | 34 | 0.110 |
Why?
|
| Science | 1 | 2016 | 236 | 0.110 |
Why?
|
| Epidemiologic Methods | 1 | 1998 | 1328 | 0.110 |
Why?
|
| Motivation | 5 | 2009 | 2020 | 0.110 |
Why?
|
| Alcoholic Intoxication | 3 | 2008 | 171 | 0.110 |
Why?
|
| Functional Laterality | 2 | 1994 | 2264 | 0.110 |
Why?
|
| Health Policy | 3 | 2010 | 2698 | 0.110 |
Why?
|
| Scapegoating | 1 | 2012 | 1 | 0.110 |
Why?
|
| Social Values | 2 | 2013 | 224 | 0.110 |
Why?
|
| Rationalization | 1 | 2012 | 6 | 0.110 |
Why?
|
| Legislation as Topic | 1 | 2013 | 76 | 0.100 |
Why?
|
| Multiple Trauma | 1 | 1995 | 369 | 0.100 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 261 | 0.100 |
Why?
|
| Sex Offenses | 2 | 2014 | 357 | 0.100 |
Why?
|
| Laboratories | 1 | 2016 | 463 | 0.100 |
Why?
|
| Causality | 1 | 2019 | 1254 | 0.100 |
Why?
|
| Forecasting | 2 | 2018 | 2945 | 0.100 |
Why?
|
| Telephone | 3 | 2000 | 630 | 0.100 |
Why?
|
| Universities | 3 | 2011 | 1005 | 0.100 |
Why?
|
| Health Promotion | 3 | 2018 | 2210 | 0.100 |
Why?
|
| Immunization Programs | 1 | 1995 | 267 | 0.100 |
Why?
|
| Wrist Injuries | 1 | 1994 | 215 | 0.100 |
Why?
|
| Economics | 2 | 1991 | 141 | 0.100 |
Why?
|
| Organizations | 1 | 1993 | 172 | 0.100 |
Why?
|
| Texas | 2 | 2010 | 410 | 0.100 |
Why?
|
| Epidemiologic Studies | 1 | 2015 | 677 | 0.100 |
Why?
|
| Mental Health | 4 | 2021 | 3275 | 0.100 |
Why?
|
| Research Personnel | 1 | 2016 | 589 | 0.090 |
Why?
|
| Respiratory Mucosa | 2 | 2008 | 439 | 0.090 |
Why?
|
| Hemolysis | 1 | 1993 | 417 | 0.090 |
Why?
|
| Walking | 2 | 1995 | 1201 | 0.090 |
Why?
|
| Dental Staff | 1 | 1990 | 14 | 0.090 |
Why?
|
| Local Government | 1 | 2011 | 83 | 0.090 |
Why?
|
| Family | 1 | 2022 | 3209 | 0.090 |
Why?
|
| Likelihood Functions | 2 | 2010 | 994 | 0.090 |
Why?
|
| Politics | 3 | 2018 | 822 | 0.090 |
Why?
|
| Formaldehyde | 1 | 1992 | 362 | 0.090 |
Why?
|
| Industry | 1 | 2013 | 362 | 0.090 |
Why?
|
| Models, Econometric | 1 | 2011 | 215 | 0.090 |
Why?
|
| Academies and Institutes | 1 | 2013 | 326 | 0.090 |
Why?
|
| Health Occupations | 3 | 2000 | 225 | 0.090 |
Why?
|
| Teaching | 1 | 2018 | 1171 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 1998 | 4352 | 0.090 |
Why?
|
| Rats | 32 | 2003 | 23760 | 0.090 |
Why?
|
| Cold Climate | 1 | 1990 | 7 | 0.090 |
Why?
|
| Health Facilities | 2 | 2000 | 578 | 0.090 |
Why?
|
| Confidence Intervals | 6 | 2011 | 2923 | 0.090 |
Why?
|
| Siblings | 1 | 2014 | 828 | 0.090 |
Why?
|
| Pilot Projects | 4 | 2017 | 8741 | 0.090 |
Why?
|
| Health Facility Administration | 1 | 1990 | 29 | 0.090 |
Why?
|
| Ozone | 1 | 1994 | 496 | 0.090 |
Why?
|
| New England | 4 | 2009 | 1058 | 0.090 |
Why?
|
| Personnel Management | 1 | 1990 | 54 | 0.090 |
Why?
|
| Odds Ratio | 9 | 2013 | 9669 | 0.090 |
Why?
|
| Animals | 52 | 2008 | 169246 | 0.080 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1992 | 255 | 0.080 |
Why?
|
| Combat Disorders | 1 | 2011 | 301 | 0.080 |
Why?
|
| Multi-Institutional Systems | 1 | 1989 | 43 | 0.080 |
Why?
|
| Myanmar | 3 | 2014 | 43 | 0.080 |
Why?
|
| Social Change | 1 | 2010 | 152 | 0.080 |
Why?
|
| Sports | 2 | 2007 | 703 | 0.080 |
Why?
|
| Awareness | 1 | 2013 | 654 | 0.080 |
Why?
|
| Mental Disorders | 4 | 2011 | 6874 | 0.080 |
Why?
|
| Attitude to Health | 2 | 2001 | 2025 | 0.080 |
Why?
|
| Forearm Injuries | 1 | 1988 | 68 | 0.080 |
Why?
|
| Physician Incentive Plans | 1 | 1990 | 165 | 0.080 |
Why?
|
| Deception | 1 | 2009 | 100 | 0.080 |
Why?
|
| Thailand | 3 | 2014 | 288 | 0.080 |
Why?
|
| Family Health | 1 | 2013 | 1255 | 0.080 |
Why?
|
| Ovalbumin | 2 | 2007 | 677 | 0.080 |
Why?
|
| Sampling Studies | 3 | 1994 | 615 | 0.080 |
Why?
|
| Educational Status | 6 | 2017 | 2515 | 0.080 |
Why?
|
| Sulfur Dioxide | 2 | 2000 | 178 | 0.080 |
Why?
|
| Ipecac | 1 | 1987 | 26 | 0.080 |
Why?
|
| Research Design | 3 | 2015 | 6211 | 0.070 |
Why?
|
| Pneumonia | 4 | 2005 | 2163 | 0.070 |
Why?
|
| Blood | 1 | 1990 | 599 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15832 | 0.070 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2007 | 301 | 0.070 |
Why?
|
| Medical Record Linkage | 1 | 2009 | 286 | 0.070 |
Why?
|
| Mice | 21 | 2008 | 82029 | 0.070 |
Why?
|
| Family Relations | 2 | 2000 | 318 | 0.070 |
Why?
|
| Child Behavior | 1 | 2013 | 864 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 1993 | 863 | 0.070 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 59629 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 1991 | 2357 | 0.070 |
Why?
|
| Financing, Government | 2 | 2000 | 473 | 0.070 |
Why?
|
| Evidence-Based Practice | 1 | 2011 | 500 | 0.070 |
Why?
|
| Hydroxyproline | 7 | 2000 | 110 | 0.070 |
Why?
|
| Earthquakes | 1 | 2009 | 192 | 0.070 |
Why?
|
| Nurses | 2 | 1995 | 2501 | 0.070 |
Why?
|
| Consensus | 1 | 2016 | 3212 | 0.070 |
Why?
|
| Judicial Role | 1 | 2006 | 38 | 0.070 |
Why?
|
| Tyrosine | 2 | 2003 | 1427 | 0.070 |
Why?
|
| Jamaica | 1 | 2006 | 54 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 331 | 0.070 |
Why?
|
| Athletic Injuries | 2 | 2011 | 1245 | 0.070 |
Why?
|
| Hospitalization | 5 | 2009 | 10840 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2003 | 1245 | 0.060 |
Why?
|
| Cell Count | 8 | 2001 | 1832 | 0.060 |
Why?
|
| Body Weight | 2 | 1994 | 4627 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 272 | 0.060 |
Why?
|
| Rhode Island | 1 | 2006 | 352 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2019 | 8080 | 0.060 |
Why?
|
| Oxidants, Photochemical | 1 | 2005 | 77 | 0.060 |
Why?
|
| Ethanol | 3 | 1997 | 1331 | 0.060 |
Why?
|
| Kentucky | 1 | 2005 | 83 | 0.060 |
Why?
|
| Morbidity | 1 | 2010 | 1755 | 0.060 |
Why?
|
| Coercion | 1 | 2005 | 68 | 0.060 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2008 | 301 | 0.060 |
Why?
|
| Men | 1 | 2005 | 64 | 0.060 |
Why?
|
| Parents | 2 | 2010 | 3595 | 0.060 |
Why?
|
| Macrophages | 7 | 2000 | 5799 | 0.060 |
Why?
|
| Infant Equipment | 1 | 2004 | 23 | 0.060 |
Why?
|
| Social Class | 1 | 2013 | 2008 | 0.060 |
Why?
|
| Military Personnel | 3 | 2011 | 1261 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 1514 | 0.060 |
Why?
|
| Angina Pectoris | 2 | 1985 | 957 | 0.060 |
Why?
|
| Seat Belts | 3 | 2004 | 60 | 0.060 |
Why?
|
| Pulmonary Alveoli | 5 | 1993 | 665 | 0.060 |
Why?
|
| Fees and Charges | 1 | 1985 | 189 | 0.060 |
Why?
|
| Environment, Controlled | 1 | 1983 | 42 | 0.060 |
Why?
|
| Alcoholism | 1 | 1994 | 1980 | 0.060 |
Why?
|
| Attitude of Health Personnel | 3 | 2016 | 3929 | 0.050 |
Why?
|
| Africa South of the Sahara | 2 | 2017 | 752 | 0.050 |
Why?
|
| Aflatoxin B1 | 2 | 1994 | 17 | 0.050 |
Why?
|
| Choice Behavior | 1 | 2009 | 848 | 0.050 |
Why?
|
| Disasters | 1 | 2009 | 521 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2002 | 287 | 0.050 |
Why?
|
| Community Health Services | 1 | 2008 | 659 | 0.050 |
Why?
|
| Child Care | 1 | 2004 | 126 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 4 | 1992 | 1627 | 0.050 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 1994 | 220 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2001 | 18349 | 0.050 |
Why?
|
| Demography | 3 | 2000 | 1641 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2015 | 9384 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2011 | 2507 | 0.050 |
Why?
|
| Accreditation | 1 | 2006 | 476 | 0.050 |
Why?
|
| Baseball | 1 | 1983 | 95 | 0.050 |
Why?
|
| Mothers | 1 | 2013 | 2209 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2005 | 10760 | 0.050 |
Why?
|
| Lipopolysaccharides | 3 | 2008 | 2219 | 0.050 |
Why?
|
| Thymus Gland | 3 | 1999 | 1266 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2016 | 20227 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 1649 | 0.050 |
Why?
|
| Peroxidase | 1 | 2005 | 610 | 0.050 |
Why?
|
| RNA, Messenger | 7 | 2000 | 12800 | 0.050 |
Why?
|
| Feedback | 2 | 2000 | 799 | 0.050 |
Why?
|
| Travel | 1 | 2008 | 805 | 0.050 |
Why?
|
| Toxicology | 1 | 1982 | 103 | 0.050 |
Why?
|
| Prejudice | 2 | 2011 | 574 | 0.050 |
Why?
|
| Neutrophils | 5 | 2008 | 3786 | 0.050 |
Why?
|
| Prospective Studies | 8 | 2015 | 54926 | 0.050 |
Why?
|
| Nitrites | 2 | 2001 | 156 | 0.050 |
Why?
|
| Lung Diseases | 2 | 2008 | 1944 | 0.050 |
Why?
|
| Lead Poisoning | 1 | 2024 | 323 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2009 | 5520 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 478 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 1991 | 3573 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 1494 | 0.040 |
Why?
|
| Hexylresorcinol | 1 | 1980 | 1 | 0.040 |
Why?
|
| Brefeldin A | 1 | 2000 | 68 | 0.040 |
Why?
|
| Criminal Psychology | 1 | 2000 | 15 | 0.040 |
Why?
|
| Air Pollutants | 3 | 2000 | 2916 | 0.040 |
Why?
|
| Epithelial Cells | 6 | 2005 | 3703 | 0.040 |
Why?
|
| Schizophrenia | 2 | 2009 | 6983 | 0.040 |
Why?
|
| Macrophage Activation | 2 | 2000 | 557 | 0.040 |
Why?
|
| Insurance Claim Review | 1 | 2004 | 744 | 0.040 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 2973 | 0.040 |
Why?
|
| Allergens | 1 | 2007 | 1443 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2002 | 580 | 0.040 |
Why?
|
| Gene Expression | 6 | 2000 | 7598 | 0.040 |
Why?
|
| Protective Devices | 1 | 2020 | 72 | 0.040 |
Why?
|
| Empirical Research | 1 | 2020 | 119 | 0.040 |
Why?
|
| Thinking | 1 | 2002 | 320 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 1997 | 10266 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2001 | 251 | 0.040 |
Why?
|
| Coronary Artery Bypass | 2 | 1986 | 2191 | 0.040 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 772 | 0.040 |
Why?
|
| Aldehydes | 1 | 1980 | 170 | 0.040 |
Why?
|
| Drowning | 1 | 1998 | 27 | 0.040 |
Why?
|
| Epidemiologic Factors | 1 | 1998 | 36 | 0.040 |
Why?
|
| Physicians | 4 | 1991 | 4598 | 0.040 |
Why?
|
| Cohort Studies | 6 | 2019 | 41754 | 0.040 |
Why?
|
| Taiwan | 1 | 1999 | 521 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2000 | 292 | 0.040 |
Why?
|
| Mice, Inbred NZB | 1 | 1998 | 57 | 0.040 |
Why?
|
| Interleukin-12 | 1 | 2001 | 577 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2007 | 1596 | 0.040 |
Why?
|
| New Zealand | 1 | 1998 | 360 | 0.040 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 1998 | 158 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2000 | 605 | 0.040 |
Why?
|
| Health Services Research | 1 | 1985 | 1815 | 0.040 |
Why?
|
| South Africa | 2 | 2016 | 1873 | 0.040 |
Why?
|
| Time Factors | 9 | 2018 | 40218 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 492 | 0.030 |
Why?
|
| Occupational Exposure | 3 | 2011 | 1807 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2002 | 3231 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1985 | 1406 | 0.030 |
Why?
|
| Life Style | 1 | 1988 | 3932 | 0.030 |
Why?
|
| Caregivers | 1 | 2009 | 2302 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1999 | 693 | 0.030 |
Why?
|
| Reference Values | 3 | 1999 | 4938 | 0.030 |
Why?
|
| Workplace | 1 | 2023 | 873 | 0.030 |
Why?
|
| Emergency Service, Hospital | 2 | 2009 | 7951 | 0.030 |
Why?
|
| Uncompensated Care | 1 | 1996 | 37 | 0.030 |
Why?
|
| Poisson Distribution | 2 | 2013 | 506 | 0.030 |
Why?
|
| Marital Status | 2 | 2013 | 426 | 0.030 |
Why?
|
| Canada | 2 | 1998 | 2130 | 0.030 |
Why?
|
| Linear Models | 1 | 2006 | 5884 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2005 | 1172 | 0.030 |
Why?
|
| Nursing Homes | 1 | 1983 | 1084 | 0.030 |
Why?
|
| Particle Size | 3 | 1997 | 1649 | 0.030 |
Why?
|
| Hepatitis B | 2 | 1992 | 711 | 0.030 |
Why?
|
| Cell Death | 1 | 2001 | 1679 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2000 | 1617 | 0.030 |
Why?
|
| Brazil | 1 | 2020 | 1250 | 0.030 |
Why?
|
| Biological Assay | 3 | 1993 | 628 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 1998 | 638 | 0.030 |
Why?
|
| Spleen | 2 | 1999 | 2295 | 0.030 |
Why?
|
| National Health Programs | 1 | 1998 | 442 | 0.030 |
Why?
|
| Carcinogens | 1 | 1997 | 453 | 0.030 |
Why?
|
| Lymph Nodes | 3 | 1997 | 3474 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1999 | 1156 | 0.030 |
Why?
|
| Body Mass Index | 4 | 2016 | 13053 | 0.030 |
Why?
|
| Cell Division | 6 | 2002 | 4473 | 0.030 |
Why?
|
| Nitric Oxide | 3 | 1999 | 2146 | 0.030 |
Why?
|
| HIV Infections | 3 | 2009 | 17569 | 0.030 |
Why?
|
| Mycotoxicosis | 1 | 1994 | 1 | 0.030 |
Why?
|
| DNA Primers | 1 | 1999 | 2828 | 0.030 |
Why?
|
| Intergenerational Relations | 1 | 1994 | 68 | 0.030 |
Why?
|
| Austria | 1 | 1994 | 208 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2000 | 3436 | 0.030 |
Why?
|
| Obesity | 1 | 2016 | 13090 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2008 | 5349 | 0.030 |
Why?
|
| Leukocytes | 2 | 1999 | 2035 | 0.030 |
Why?
|
| War Crimes | 1 | 2013 | 22 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 1903 | 0.030 |
Why?
|
| Nigeria | 1 | 2016 | 781 | 0.030 |
Why?
|
| Catalase | 2 | 1992 | 215 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1998 | 785 | 0.030 |
Why?
|
| Arizona | 2 | 2004 | 108 | 0.030 |
Why?
|
| Verbal Behavior | 1 | 1994 | 336 | 0.030 |
Why?
|
| Louisiana | 1 | 2013 | 104 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 197 | 0.030 |
Why?
|
| Hawaii | 1 | 2013 | 101 | 0.030 |
Why?
|
| Superoxide Dismutase | 5 | 1995 | 596 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 6 | 2008 | 22379 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1993 | 134 | 0.030 |
Why?
|
| Collagen | 2 | 2000 | 2643 | 0.030 |
Why?
|
| SRS-A | 1 | 1992 | 132 | 0.030 |
Why?
|
| Chemistry, Physical | 1 | 1992 | 153 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2008 | 4530 | 0.030 |
Why?
|
| Social Responsibility | 1 | 1995 | 382 | 0.030 |
Why?
|
| Los Angeles | 1 | 1993 | 245 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 1992 | 486 | 0.030 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 440 | 0.030 |
Why?
|
| Connecticut | 1 | 2013 | 366 | 0.030 |
Why?
|
| Bromodeoxyuridine | 3 | 1998 | 310 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 1434 | 0.020 |
Why?
|
| Phosphorylation | 4 | 2008 | 8317 | 0.020 |
Why?
|
| Gender Identity | 1 | 2018 | 770 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 10474 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 39348 | 0.020 |
Why?
|
| Tanzania | 1 | 2016 | 1407 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 3 | 1995 | 5536 | 0.020 |
Why?
|
| DNA | 2 | 1998 | 7214 | 0.020 |
Why?
|
| DNA Adducts | 1 | 1992 | 95 | 0.020 |
Why?
|
| Hospitals, General | 1 | 1996 | 809 | 0.020 |
Why?
|
| Uganda | 1 | 2016 | 1361 | 0.020 |
Why?
|
| Harm Reduction | 1 | 2013 | 143 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 1992 | 281 | 0.020 |
Why?
|
| Coronary Disease | 1 | 1986 | 5919 | 0.020 |
Why?
|
| Cells, Cultured | 8 | 2001 | 19015 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 1993 | 426 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2000 | 2211 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 1996 | 840 | 0.020 |
Why?
|
| Taxes | 1 | 2013 | 220 | 0.020 |
Why?
|
| Respiratory System | 1 | 1994 | 564 | 0.020 |
Why?
|
| Dentists | 1 | 1992 | 176 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1998 | 2149 | 0.020 |
Why?
|
| Fibronectins | 1 | 1994 | 722 | 0.020 |
Why?
|
| Hydroxylysine | 1 | 1989 | 4 | 0.020 |
Why?
|
| District of Columbia | 2 | 2000 | 159 | 0.020 |
Why?
|
| Albumins | 1 | 1992 | 577 | 0.020 |
Why?
|
| Religion | 1 | 2013 | 376 | 0.020 |
Why?
|
| Group Processes | 1 | 2011 | 227 | 0.020 |
Why?
|
| Personality | 1 | 1993 | 559 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 1990 | 406 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1992 | 597 | 0.020 |
Why?
|
| Insurance Claim Reporting | 1 | 2009 | 166 | 0.020 |
Why?
|
| Influenza A virus | 1 | 1992 | 460 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6231 | 0.020 |
Why?
|
| Silicon | 1 | 1989 | 143 | 0.020 |
Why?
|
| Mineral Fibers | 2 | 2000 | 26 | 0.020 |
Why?
|
| Selection Bias | 1 | 2010 | 360 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 1983 | 4310 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 1609 | 0.020 |
Why?
|
| Acculturation | 1 | 2010 | 179 | 0.020 |
Why?
|
| Consumer Advocacy | 1 | 1989 | 83 | 0.020 |
Why?
|
| Brain Injuries | 1 | 2000 | 2057 | 0.020 |
Why?
|
| Hospitals, Public | 1 | 2009 | 204 | 0.020 |
Why?
|
| Utilization Review | 1 | 2009 | 381 | 0.020 |
Why?
|
| Drug Storage | 1 | 1987 | 52 | 0.020 |
Why?
|
| British Columbia | 1 | 2008 | 240 | 0.020 |
Why?
|
| Models, Biological | 4 | 1992 | 9495 | 0.020 |
Why?
|
| Marriage | 1 | 2009 | 351 | 0.020 |
Why?
|
| Drug Stability | 1 | 1987 | 291 | 0.020 |
Why?
|
| Pregnancy | 2 | 2023 | 30256 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1993 | 1441 | 0.020 |
Why?
|
| Breath Tests | 1 | 2008 | 300 | 0.020 |
Why?
|
| Length of Stay | 3 | 2008 | 6498 | 0.020 |
Why?
|
| Culture Media, Conditioned | 2 | 2001 | 521 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 326 | 0.020 |
Why?
|
| Psychopathology | 1 | 2009 | 434 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 5505 | 0.020 |
Why?
|
| Community Health Centers | 1 | 2010 | 469 | 0.020 |
Why?
|
| Office Visits | 1 | 1990 | 595 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 1990 | 548 | 0.020 |
Why?
|
| Comorbidity | 2 | 2011 | 10590 | 0.020 |
Why?
|
| Mucus | 1 | 2007 | 346 | 0.020 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1985 | 113 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2007 | 348 | 0.020 |
Why?
|
| Overweight | 1 | 2016 | 2448 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7608 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1990 | 966 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 381 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 2003 | 3590 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2009 | 1157 | 0.010 |
Why?
|
| Epithelium | 3 | 1996 | 1607 | 0.010 |
Why?
|
| Air Pollution | 1 | 1998 | 2374 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2008 | 1049 | 0.010 |
Why?
|
| Virus Replication | 1 | 1992 | 2458 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1999 | 1134 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1995 | 2697 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1990 | 1196 | 0.010 |
Why?
|
| Antioxidants | 1 | 1992 | 1673 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1993 | 2418 | 0.010 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 1972 | 0.010 |
Why?
|
| Seasons | 1 | 1990 | 1524 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 453 | 0.010 |
Why?
|
| Japan | 1 | 2008 | 1418 | 0.010 |
Why?
|
| China | 1 | 2009 | 2395 | 0.010 |
Why?
|
| Organ Size | 3 | 1997 | 2267 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2008 | 1042 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2007 | 582 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1986 | 312 | 0.010 |
Why?
|
| Body Burden | 1 | 1983 | 158 | 0.010 |
Why?
|
| Professional Practice | 1 | 1985 | 314 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1997 | 944 | 0.010 |
Why?
|
| Licensure, Medical | 1 | 1983 | 72 | 0.010 |
Why?
|
| Eosinophilia | 1 | 2007 | 556 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2008 | 1078 | 0.010 |
Why?
|
| Genes, jun | 1 | 2002 | 69 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 9561 | 0.010 |
Why?
|
| India | 1 | 2009 | 2334 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2002 | 11928 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2009 | 1988 | 0.010 |
Why?
|
| Trauma Centers | 1 | 2008 | 951 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2000 | 11669 | 0.010 |
Why?
|
| Information Services | 1 | 1983 | 239 | 0.010 |
Why?
|
| Genes, fos | 1 | 2002 | 176 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 816 | 0.010 |
Why?
|
| Vermont | 2 | 1991 | 80 | 0.010 |
Why?
|
| Recurrence | 1 | 1994 | 8509 | 0.010 |
Why?
|
| Phenotype | 1 | 2000 | 16726 | 0.010 |
Why?
|
| Acute Disease | 2 | 2008 | 7243 | 0.010 |
Why?
|
| Receptors, Fc | 2 | 1996 | 537 | 0.010 |
Why?
|
| Rotation | 1 | 1983 | 517 | 0.010 |
Why?
|
| Molsidomine | 1 | 2001 | 22 | 0.010 |
Why?
|
| Blotting, Northern | 2 | 1994 | 1550 | 0.010 |
Why?
|
| Bronchi | 1 | 2005 | 850 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 474 | 0.010 |
Why?
|
| Immunohistochemistry | 3 | 2003 | 11095 | 0.010 |
Why?
|
| Nitric Oxide Donors | 1 | 2001 | 126 | 0.010 |
Why?
|
| Diffusion | 1 | 1982 | 815 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 1 | 1991 | 2176 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2013 | 81762 | 0.010 |
Why?
|
| Phagocyte Bactericidal Dysfunction | 1 | 2000 | 8 | 0.010 |
Why?
|
| Language | 1 | 2010 | 1557 | 0.010 |
Why?
|
| Foundations | 1 | 2000 | 96 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 611 | 0.010 |
Why?
|
| Methods | 1 | 1980 | 1066 | 0.010 |
Why?
|
| Drinking Behavior | 1 | 2000 | 103 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2008 | 2493 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 637 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2001 | 351 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2004 | 752 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1994 | 2560 | 0.010 |
Why?
|
| Efficiency | 1 | 1982 | 479 | 0.010 |
Why?
|
| Philosophy, Medical | 1 | 1998 | 78 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 1991 | 325 | 0.010 |
Why?
|
| Employment | 1 | 1985 | 1110 | 0.010 |
Why?
|
| Cell Survival | 2 | 2000 | 5777 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 354 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 24315 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 1998 | 131 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1980 | 449 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 1983 | 1667 | 0.010 |
Why?
|
| Free Radicals | 1 | 1998 | 238 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2000 | 425 | 0.010 |
Why?
|
| Biological Transport | 2 | 1992 | 2085 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 321 | 0.010 |
Why?
|
| Bleomycin | 1 | 1998 | 492 | 0.010 |
Why?
|
| Wisconsin | 1 | 1996 | 122 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 1998 | 514 | 0.010 |
Why?
|
| Liver | 1 | 1992 | 7577 | 0.010 |
Why?
|
| Inflammation | 2 | 1994 | 10873 | 0.010 |
Why?
|
| Germany | 1 | 1998 | 883 | 0.010 |
Why?
|
| Feces | 1 | 1982 | 1511 | 0.010 |
Why?
|
| Blotting, Western | 2 | 1994 | 5027 | 0.010 |
Why?
|
| Toxicity Tests | 1 | 1996 | 114 | 0.010 |
Why?
|
| Sulfates | 1 | 1996 | 379 | 0.010 |
Why?
|
| Physical Fitness | 1 | 2000 | 744 | 0.010 |
Why?
|
| Coffee | 1 | 2000 | 594 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1997 | 564 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 1998 | 435 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 911 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 1998 | 344 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 1994 | 63 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1994 | 79 | 0.010 |
Why?
|
| HIV-1 | 1 | 1992 | 6961 | 0.010 |
Why?
|
| Cytochalasin B | 1 | 1994 | 74 | 0.010 |
Why?
|
| Hospital Charges | 1 | 1996 | 347 | 0.010 |
Why?
|
| Kinetics | 2 | 1992 | 6329 | 0.010 |
Why?
|
| Thorax | 1 | 1997 | 557 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 1994 | 244 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1703 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1999 | 3096 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1667 | 0.010 |
Why?
|
| Marijuana Abuse | 1 | 1996 | 409 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2000 | 2434 | 0.010 |
Why?
|
| Calcimycin | 1 | 1992 | 214 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 1992 | 128 | 0.010 |
Why?
|
| Pneumoconiosis | 1 | 1991 | 32 | 0.010 |
Why?
|
| Refusal to Treat | 1 | 1992 | 43 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9523 | 0.010 |
Why?
|
| Zymosan | 1 | 1992 | 134 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14488 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 1930 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1994 | 4176 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 2227 | 0.010 |
Why?
|
| Microscopy, Polarization | 1 | 1991 | 88 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1991 | 135 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2007 | 3463 | 0.010 |
Why?
|
| Insurance, Health | 1 | 1983 | 2517 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2000 | 9015 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1991 | 66 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3814 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 1992 | 259 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1992 | 398 | 0.010 |
Why?
|
| Retirement | 1 | 1991 | 198 | 0.010 |
Why?
|
| Hospital Costs | 1 | 1996 | 957 | 0.010 |
Why?
|
| Disabled Persons | 1 | 2000 | 1210 | 0.010 |
Why?
|
| Desmosine | 1 | 1989 | 19 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1991 | 445 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2001 | 3139 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10101 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1994 | 1393 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1986 | 14783 | 0.010 |
Why?
|
| Decision Making, Organizational | 1 | 1990 | 136 | 0.010 |
Why?
|
| Health Status | 1 | 1982 | 4091 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2300 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1991 | 863 | 0.000 |
Why?
|
| Salaries and Fringe Benefits | 1 | 1990 | 263 | 0.000 |
Why?
|
| Phospholipids | 1 | 1990 | 787 | 0.000 |
Why?
|
| Intubation, Intratracheal | 1 | 1994 | 1359 | 0.000 |
Why?
|
| Antibodies | 1 | 1994 | 2421 | 0.000 |
Why?
|
| Medical Records | 1 | 1991 | 1410 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1992 | 2937 | 0.000 |
Why?
|
| Hypertension | 1 | 1985 | 8616 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1991 | 873 | 0.000 |
Why?
|
| Proteins | 2 | 1990 | 6009 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1990 | 997 | 0.000 |
Why?
|
| Career Choice | 1 | 1990 | 769 | 0.000 |
Why?
|
| Quality of Life | 1 | 1985 | 13490 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6514 | 0.000 |
Why?
|
| Heart Failure | 1 | 1985 | 11879 | 0.000 |
Why?
|
| Radiography | 1 | 1991 | 6983 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2002 | 23645 | 0.000 |
Why?
|
| Lipids | 1 | 1990 | 3343 | 0.000 |
Why?
|
| Mutation | 1 | 2002 | 30238 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1992 | 14729 | 0.000 |
Why?
|
| Physician-Patient Relations | 1 | 1990 | 3269 | 0.000 |
Why?
|
| Neoplasms | 1 | 2000 | 22371 | 0.000 |
Why?
|